BINDING AFFINITIES OF HIV ASPARTYL PROTEASE INHIBITORS
$43,625P41FY2000RRNIH
Columbia Univ New York Morningside, New York NY
Investigators
Linked publications & trials
Paper 15027866Paper 15027865Paper 14611245Paper 12112702Paper 11960480Paper 11948578Paper 11835490Paper 11457123Paper 11352713
Abstract
Wearetryingtocalculatetherelativebinding-freeenergiesof various drugs to the HIV aspartyl protease. We have chosen a series of closely related compounds for which both high resolution x-ray structures and binding affinities are available. Preliminary results utilize a continuum solvation model and the OPLS-AA force field of Jorgensen and coworkers are highly encouraging. A. Scientific Subproject
View original record on NIH RePORTER →